Research Projects
SCN1A Supplementation for Reversion of Genetic Encephalopathies
Researcher | Principal Investigator
Gene Therapy for Monogenic Encephalopathies Research Group
Research Division
DNA and RNA Medicine Division
Project information
“SCN1A Supplementation for the Review of Genetic Encephalopathies” is a project of the Research Group on Gene Therapy for Congenital Encephalopathies, part of the Gene Therapy for Rare Diseases program at CIMA, University of Navarra.
Project PID2021-128587OB-I00 funded by:
- Convocation: Proyectos de Generación del Conocimiento 2021
- Start date: September 3, 2022
- End date: September 30, 2025
- Funder: Ministerio de Ciencia, Innovación y Universidades
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us.